AlloMap Testing Summary - Vanderbilt University

AlloMap testing is a noninvasive method for determining the risk of acute cellular rejection (ACR) in heart transplant recipients. The test translates the complex signals of the immune system’s multiple genes and pathways, specifically those associated with heart transplant ACR, into an objective, actionable score. ................
................